RGC
NXGN

Roberts, Glore & Co’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Roberts, Glore & Co’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,157
Closed -$155K – 143
2017
Q1 		$155K Sell
10,157
-6,175
-38% -$90.9K 0.11% 141
2016
Q4 		$215K Sell
16,332
-5,450
-25% -$69.8K 0.15% 138
2016
Q3 		$247K Sell
21,782
-1,375
-6% -$16.5K 0.18% 121
2016
Q2 		$276K Sell
23,157
-1,143
-5% -$15.4K 0.21% 110
2016
Q1 		$370K Sell
24,300
-13,450
-36% -$204K 0.28% 88
2015
Q4 		$609K Sell
37,750
-4,200
-10% -$61.3K 0.46% 62
2015
Q3 		$524K Sell
41,950
-3,550
-8% -$48.7K 0.41% 70
2015
Q2 		$754K Sell
45,500
-2,100
-4% -$33.8K 0.53% 53
2015
Q1 		$761K Sell
47,600
-1,600
-3% -$26.5K 0.53% 51
2014
Q4 		$767K Sell
49,200
-24,425
-33% -$357K 0.51% 52
2014
Q3 		$1.01M Buy
73,625
+3,675
+5% +$55.8K 0.7% 46
2014
Q2 		$1.12M Sell
69,950
-200
-0.3% -$3.16K 0.76% 40
2014
Q1 		$1.18M Buy
70,150
+2,800
+4% +$50.8K 0.82% 38
2013
Q4 		$1.42M Buy
67,350
+100
+0.1% +$2.25K 0.98% 37
2013
Q3 		$1.46M Sell
67,250
-18,150
-21% -$387K 1.08% 30
2013
Q2 		$1.6M Buy
+85,400
New +$1.56M 0.98% 34

Other funds holding NXGN

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Roberts, Glore & Co's NXGN Position: Q2 2017 in Review

Roberts, Glore & Co sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q2 2017, closing a stake of 10,157 shares — an estimated $155K sold.

Roberts, Glore & Co first reported a position in NXGN in Q2 2013 and held it in 16 quarters. The position peaked at $1.6M in Q2 2013. 185 funds tracked by Wall St. Rank hold NXGN as of Q2 2017.

  • Roberts, Glore & Co reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Roberts, Glore & Co sold 10,157 NextGen Healthcare, Inc. Common Stock shares in Q2 2017, an estimated $155K.
  • Roberts, Glore & Co first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • Roberts, Glore & Co's NextGen Healthcare, Inc. Common Stock position peaked at $1.6M in Q2 2013.
  • 185 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q2 2017.

Based on Roberts, Glore & Co's 13F filing for Q2 2017, filed 15 Aug 2017.